Shares in Standard Life Equity Income look 'cheap' after 'Brexit' hits manager Thomas Moore's favoured FTSE 250 stocks.
Barclays jumps to top of FTSE 100 as bank reassures investors 'Brexit' hasn't derailed plans to reshape business.
Alastair Mundy, manager of the Temple Bar investment trust, has warned 'anti-establishment fervour' could spell trouble for shares.
A roundup of fund manager and analyst commentary on shares, also including IG Design Group and Standard Life European Private Equity.
And UK exports grow faster than global rivals for first time since 2006 as businesses target non-EU markets.
Coutts, banker to the Queen, has taken a £139 million hit as its pays client compensation in review of every investment dating back to 1957.
Stocks initially were dragged lower by Ford Motor, which posted poor second-quarter profit.
And new Hinkley Point nuclear plant in doubt as Government delays decision despite EDF approval for £18 billion project.
Investment trust veterans Alan Hodson and Carolan Dobson have been appointed to the board of Woodford Patient Capital.
Markets have rallied after the initial shock of the 'Brexit' vote, meaning it could be time to take some profits, argues Adrian Lowcock.
Rolls-Royce shares soar amid confidence the worst for the engineering group is over, but FTSE falls as investors fret over Shell's dividends.
Lloyds sparks investor fears over dividends, saying 'Brexit' vote likely to hit business and cutting 3,000 jobs.
A roundup of fund manager commentary on shares, also including HSBC and Hadrian’s Wall.
And FTSE 100 hits one-year high and FTSE 250 erases post-Brexit losses as UK economy grows by 0.6%.
After the bell, Facebook posted quarterly results that sent its stock 6% higher.
'Brexit' has sparked global growth downgrades but that should not distract investors from the growing threat posed by China.
Our roundup of analyst views and investment trust news highlights Fidelity Special Values looking 'cheap' and Electra facing criticism.
ITV jumps while Taylor Wimpey leads house builders higher as both companies issue robust updates despite 'Brexit' vote.
Volatile biotech stocks have had a rough year but bids and takeovers could propel a post-'Brexit' rally, suggests a leading investor.
A roundup of fund manager commentary on shares, also including Balfour Beatty and GCP Student Living.